{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:25:15Z","timestamp":1771935915896,"version":"3.50.1"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence of rheumatic aortic regurgitation (AR) is higher than that of aortic stenosis in developing countries, but the efficacy of transcatheter aortic valve replacement (TAVR) in high surgical risk patients with severe AR remains unknown. Our goal was to explore the differences in clinical outcomes of TAVR in patients with rheumatic and non-rheumatic AR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>144 Rheumatic and 417 nonrheumatic patients with severe AR were prospectively enrolled from January 2018 to December 2021. All patients underwent transapical TAVR with J-Valve after evaluation by computed tomography angiography and transthoracic echocardiography before the procedure. The primary end point was 3-year all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The average age was 71.2 [interquartile range (IQR): 66.0\u201376.0] years, and the Society of Thoracic Surgeons score was 4.8 (IQR: 3.4\u20136.1) %. The proportion of patients with rheumatic AR who developed\u2009\u2265\u2009mild PVL was lower than the proportion of patients with non-rheumatic AR (5.6% vs. 11.3%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001). At a median follow-up of 39.7 (IQR: 36.4\u201341.8) months, no difference was observed in the 3-year all-cause mortality (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.740) between the two groups. After multivariate adjustment, the Society of Thoracic Surgeons score, higher frailty and larger aortic angulation were associated with 3-year all-cause mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For patients with rheumatic AR, the clinical outcomes were similar to those of patients with non-rheumatic AR. TAVR can be one of the feasible treatment options for such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1662827","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:57:05Z","timestamp":1771397825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of transcatheter aortic valve replacement in rheumatic aortic regurgitation: a prospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Yaojie","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Xijing Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Xijing Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengen","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Xijing Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Xijing Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinbo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, People\u2019s Hospital of NingXia Hui Autonomous Region","place":["NingXia, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Xijing Hospital","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1161\/CIRCULATIONAHA.112.114199","article-title":"Rheumatic heart disease: the tip of the iceberg","volume":"125","author":"Sliwa","year":"2012","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American heart association","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jtcvs.2020.01.053","article-title":"Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease","volume":"162","author":"Fu","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0140-6736(17)31608-2","article-title":"Eliminating acute rheumatic fever and rheumatic heart disease","volume":"390","author":"Yacoub","year":"2017","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/acs.2019.05.01","article-title":"Rheumatic aortic valve disease-when and who to repair?","volume":"8","author":"Afifi","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1161\/CIR.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/heartasia-2015-010650","article-title":"Choice of prosthetic heart valve in a developing country","volume":"8","author":"Choudhary","year":"2016","journal-title":"Heart Asia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","article-title":"Transcatheter aortic valve replacement in pure native aortic valve regurgitation","volume":"70","author":"Yoon","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.jacc.2021.02.032","article-title":"Transcatheter versus surgical aortic valve replacement in patients with rheumatic aortic stenosis","volume":"77","author":"Mentias","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehp530","article-title":"Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study","volume":"31","author":"Sliwa","year":"2010","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","article-title":"Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study","volume":"103","author":"Andell","year":"2017","journal-title":"Heart"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1093\/eurheartj\/ehz187","article-title":"Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort","volume":"40","author":"Kundi","year":"2019","journal-title":"Eur Heart J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jcin.2015.08.021","article-title":"A new transcatheter aortic valve replacement system for predominant aortic regurgitation implantation of the J-valve and early outcome","volume":"8","author":"Wei","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","article-title":"Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research","volume":"42","author":"G\u00e9n\u00e9reux","year":"2021","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pmedr.2018.10.008","article-title":"The global burden of multiple chronic conditions: a narrative review","volume":"12","author":"Hajat","year":"2018","journal-title":"Prev Med Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/j.jcin.2019.06.020","article-title":"Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease","volume":"12","author":"Chahine","year":"2019","journal-title":"J Am Coll Cardiol Intv"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1662827\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:32:51Z","timestamp":1771932771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1662827\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":16,"alternative-id":["10.3389\/fcvm.2026.1662827"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1662827","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1662827"}}